AKT1 and cholangiocarcinoma: In order to evaluate the underlying mechanism involved in silencing C1GALT1-mediated CCA progression, C1GALT1 expression was suppressed using siC1GALT1 or siControl in KKU-055 and KKU-100 cells, and survival markers including BCL2, AKT, and ERK were determined.